Jeffrey W. Sherman

2013

In 2013, Jeffrey W. Sherman earned a total compensation of $916.3K as Executive Vice President, Development, Manufacturing and Regulatory Affairs, and Chief Medical Officer at Horizon Pharma, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$198,172
Option Awards$89,250
Salary$396,340
Stock Awards$231,914
Other$600
Total$916,276

Sherman received $396.3K in salary, accounting for 43% of the total pay in 2013.

Sherman also received $198.2K in non-equity incentive plan, $89.3K in option awards, $231.9K in stock awards and $600 in other compensation.

Rankings

In 2013, Jeffrey W. Sherman's compensation ranked 7,024th out of 12,286 executives tracked by ExecPay. In other words, Sherman earned more than 42.8% of executives.

ClassificationRankingPercentile
All
7,024
out of 12,286
43rd
Division
Manufacturing
2,499
out of 4,612
46th
Major group
Chemicals And Allied Products
766
out of 1,466
48th
Industry group
Drugs
568
out of 1,160
51st
Industry
Pharmaceutical Preparations
451
out of 890
49th
Source: SEC filing on June 2, 2014.

Sherman's colleagues

We found four more compensation records of executives who worked with Jeffrey W. Sherman at Horizon Pharma in 2013.

2013

Timothy Walbert

Horizon Pharma

Chief Executive Officer

2013

Todd Smith

Horizon Pharma

Executive Vice President and Chief Commercial Officer

2013

Robert De Vaere

Horizon Pharma

Chief Financial Officer

2013

Michael Adatto

Horizon Pharma

Former Senior Vice President, Managed Care and Commercial Development

You may also like